On November 21, 2022, Curevo, Inc. closed the transaction. The company has issued 8,382,933 shares for gross proceeds of $22,000,002 in the transaction. The transaction included participation from seven investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.55 USD | +1.85% | +2.71% | +7.96% |
May. 03 | Consumer Cos Gain on Mortgage Rate Hopes - Consumer Roundup | DJ |
May. 03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
113,500 KRW | -1.90% | +1.43% | 956M | ||
32.55 USD | +1.85% | +2.71% | 5.22B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.96% | 5.22B | |
-5.90% | 114B | |
-5.79% | 87.22B | |
+9.71% | 64.53B | |
+20.26% | 62.28B | |
+9.51% | 42.63B | |
+10.30% | 41.73B | |
+19.41% | 34.99B | |
+3.54% | 24.9B | |
-3.96% | 22.41B |
- Stock Market
- Equities
- JHG Stock
- News Janus Henderson Group plc
- Curevo, Inc. announced that it has received $22.000002 million in funding from Janus Henderson Group plc, RA Capital Management, L.P., Adjuvant Capital, LP, GC Biopharma Corp. and other investors